The initiation of coverage by Barclays with an Overweight rating and a high price target of $101 is likely to be viewed positively by investors, potentially leading to a short-term increase in Centene's stock price. The Overweight rating suggests that Barclays analysts believe CNC will outperform the market or its sector, which could attract more investors to the stock.